These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


293 related items for PubMed ID: 21514273

  • 1. Msx2 is required for TNF-α-induced canonical Wnt signaling in 3T3-L1 preadipocytes.
    Qadir AS, Lee HL, Baek KH, Park HJ, Woo KM, Ryoo HM, Baek JH.
    Biochem Biophys Res Commun; 2011 May 13; 408(3):399-404. PubMed ID: 21514273
    [Abstract] [Full Text] [Related]

  • 2. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD.
    Bone; 2008 Apr 13; 42(4):669-80. PubMed ID: 18294945
    [Abstract] [Full Text] [Related]

  • 3. AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/β-catenin pathway in 3T3-L1 adipocytes.
    Lee H, Kang R, Bae S, Yoon Y.
    Int J Mol Med; 2011 Jul 13; 28(1):65-71. PubMed ID: 21491080
    [Abstract] [Full Text] [Related]

  • 4. Wnt5b partially inhibits canonical Wnt/beta-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes.
    Kanazawa A, Tsukada S, Kamiyama M, Yanagimoto T, Nakajima M, Maeda S.
    Biochem Biophys Res Commun; 2005 May 06; 330(2):505-10. PubMed ID: 15796911
    [Abstract] [Full Text] [Related]

  • 5. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E, Takahashi-Yanaga F, Miwa Y, Hirata M, Watanabe Y, Sato N, Morimoto S, Hirofuji T, Maeda K, Sasaguri T.
    J Bone Miner Res; 2006 Aug 06; 21(8):1307-16. PubMed ID: 16869729
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. WNT/β-catenin pathway mediates the anti-adipogenic effect of platycodin D, a natural compound found in Platycodon grandiflorum.
    Lee H, Bae S, Kim YS, Yoon Y.
    Life Sci; 2011 Sep 12; 89(11-12):388-94. PubMed ID: 21798269
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid inhibits adipogenesis via activation of Wnt signaling pathway in 3T3-L1 preadipocytes.
    Kim DM, Choi HR, Park A, Shin SM, Bae KH, Lee SC, Kim IC, Kim WK.
    Biochem Biophys Res Commun; 2013 May 10; 434(3):455-9. PubMed ID: 23583383
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes.
    Freise C, Erben U, Neuman U, Kim K, Zeitz M, Somasundaram R, Ruehl M.
    J Nutr Biochem; 2010 Dec 10; 21(12):1170-7. PubMed ID: 20092995
    [Abstract] [Full Text] [Related]

  • 11. Effect of Wnt-1 inducible signaling pathway protein-2 (WISP-2/CCN5), a downstream protein of Wnt signaling, on adipocyte differentiation.
    Inadera H, Shimomura A, Tachibana S.
    Biochem Biophys Res Commun; 2009 Feb 20; 379(4):969-74. PubMed ID: 19135425
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells.
    Li HX, Luo X, Liu RX, Yang YJ, Yang GS.
    Mol Cell Endocrinol; 2008 Sep 10; 291(1-2):116-24. PubMed ID: 18584948
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
    Yang F, Zeng Q, Yu G, Li S, Wang CY.
    Cell Signal; 2006 May 10; 18(5):679-87. PubMed ID: 16084063
    [Abstract] [Full Text] [Related]

  • 17. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 10; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.